Method matters: a comparative evaluation of tissue-derived extracellular vesicle isolation methods in non-small cell lung cancer

Tumor-derived small extracellular vesicles (sEVs), including exosomes, affect immune cell function and contribute to the establishment of an immunosuppressive tumor microenvironment. Most studies on tumor-derived sEVs focus on vesicles isolated from cancer cell-conditioned media, but these may differ substantially from those present in the native tumor microenvironment. Direct isolation of sEVs from tumor tissue offers a more biologically relevant approach, but isolated material is often contaminated with intracellular material, protein aggregates, and blood-derived components, making the choice of isolation method critical for reliable downstream analyses. In this study, we compared six EV isolation methods for non-small cell lung cancer tissue: ultracentrifugation, iodixanol-cushioned ultracentrifugation, and four commercial kits based on vesicle precipitation, membrane affinity, immunoaffinity, and phosphatidylserine binding. Using transmission electron microscopy, CD9-targeted fluorescence nanoparticle tracking analysis, and quantitative LC-MS/MS proteomics, we assessed the isolated preparations based on characteristics relevant to sEV characterization, including particle size, vesicle morphology, CD9⁺ particle abundance, and EV-associated protein enrichment. Ultracentrifugation and iodixanol-cushioned ultracentrifugation yielded samples showing the strongest evidence of sEV enrichment, as indicated by vesicle morphology, abundance of CD9⁺ particles, and enrichment of EV-associated proteins. The phosphatidylserine-binding approach resulted in moderate sEV enrichment, whereas the other tested approaches predominantly isolated non-vesicular contaminants. While iodixanol-cushioned ultracentrifugation achieved the highest purity, ultracentrifugation provided comparable purity with considerably higher yield of CD9⁺ particles, used here as a proxy for sEV recovery. Overall, ultracentrifugation offers the best balance between purity and isolation efficiency, making it a practical choice for tissue-derived EV studies and downstream molecular analyses in solid tumors.

Authors

Institutions

Publication Details

Journal
Cell Communication and Signaling
Published
2026-11-14
DOI
https://doi.org/10.1186/s12964-026-03355-4
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Method matters: a comparative evaluation of tissue-derived extracellular vesicle isolation methods in non-small cell lung cancer

Anna Biernacka, Danuta Gutowska‐Owsiak, Witold Rzyman, Sachin Kote et al.
Cell Communication and Signaling
Extracellular vesicles in disease
article

Method matters: a comparative evaluation of tissue-derived extracellular vesicle isolation methods in non-small cell lung cancer

Anna Biernacka, Danuta Gutowska‐Owsiak, Witold Rzyman, Sachin Kote, Jakub Faktor, Aneta Zebrowska, Zuzanna Urban‐Wójciuk, Magdalena Sitkiewicz, Monika Pietrowska, Artur Piróg, Magdalena Szczepanowska, Natalia Maria Marek-Trzonkowska, Ines Papak, Tomasz Marjański, Martyna Siewiera
article en

Abstract

Tumor-derived small extracellular vesicles (sEVs), including exosomes, affect immune cell function and contribute to the establishment of an immunosuppressive tumor microenvironment. Most studies on tumor-derived sEVs focus on vesicles isolated from cancer cell-conditioned media, but these may differ substantially from those present in the native tumor microenvironment. Direct isolation of sEVs from tumor tissue offers a more biologically relevant approach, but isolated material is often contaminated with intracellular material, protein aggregates, and blood-derived components, making the choice of isolation method critical for reliable downstream analyses. In this study, we compared six EV isolation methods for non-small cell lung cancer tissue: ultracentrifugation, iodixanol-cushioned ultracentrifugation, and four commercial kits based on vesicle precipitation, membrane affinity, immunoaffinity, and phosphatidylserine binding. Using transmission electron microscopy, CD9-targeted fluorescence nanoparticle tracking analysis, and quantitative LC-MS/MS proteomics, we assessed the isolated preparations based on characteristics relevant to sEV characterization, including particle size, vesicle morphology, CD9⁺ particle abundance, and EV-associated protein enrichment. Ultracentrifugation and iodixanol-cushioned ultracentrifugation yielded samples showing the strongest evidence of sEV enrichment, as indicated by vesicle morphology, abundance of CD9⁺ particles, and enrichment of EV-associated proteins. The phosphatidylserine-binding approach resulted in moderate sEV enrichment, whereas the other tested approaches predominantly isolated non-vesicular contaminants. While iodixanol-cushioned ultracentrifugation achieved the highest purity, ultracentrifugation provided comparable purity with considerably higher yield of CD9⁺ particles, used here as a proxy for sEV recovery. Overall, ultracentrifugation offers the best balance between purity and isolation efficiency, making it a practical choice for tissue-derived EV studies and downstream molecular analyses in solid tumors.

Cell Communication and Signaling
Medical University of Silesia (PL), University of Gdańsk (PL), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Gdańsk Medical University (PL), Polish Academy of Sciences (PL)
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon